For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Saint-Cloud 92210

0 studies enrolling now · 1 studies all time

What they study most

HER-2 Positive Breast Cancer, Hormone Receptor Positive Breast Cancer

Studies at this site

• A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer — Completed